Fang Li

hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis

Jingtao Li, Shan Li, Fangmin Song, 2020, Aging.

Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats.

G. Zhan, Fang Li, H. Tan, 2015, World journal of gastroenterology.

Analysis of Plasmodium falciparum Na+/H+ exchanger (pfnhe1) polymorphisms among imported African malaria parasites isolated in Wuhan, Central China

Jian Li, Ming-xing Xu, Fang Li, 2019, BMC Infectious Diseases.

Immune cells within the tumor microenvironment: biological functions and roles in cancer immunotherapy.

Jian Li, Jing Yang, Y. Lei, 2019, Cancer letters.

MicroRNA‐26a–interleukin (IL)‐6–IL‐17 axis regulates the development of non‐alcoholic fatty liver disease in a murine model

G. Zhan, G. Li, R. Li, 2016, Clinical and experimental immunology.

circRNA 001306 enhances hepatocellular carcinoma growth by up‐regulating CDK16 expression via sponging miR‐584‐5p

Shan Li, Fang Li, Qian Liu, 2020, Journal of cellular and molecular medicine.